Predictive factors of positive circumferential resection margin after radiochemotherapy for rectal cancer: The French randomised trial ACCORD12/0405 PRODIGE 2

European Journal of Cancer

Volumn 49, Issue 1, 2013, Pages 82-89

  Rullier, Anne ^a   Gourgou Bourgade, Sophie ^b   Jarlier, Marta ^b   Bibeau, Frédéric ^b   Chassagne Clément, Catherine ^c   Hennequin, Christophe ^d   Tisseau, Laurent ^e   Leroux, Agnès ^f   Ettore, Francette ^g   Peoc'H, Michel ^e   Diebold, Marie Agnès ^h   Robin, Yves Marie ⁱ   Kleinclaus, Isabelle ^j   Mineur, Laurent ^k   Petitjean, Christophe ^l   Mosnier, Jean François ^m   Soubeyran, Isabelle ⁿ   Padilla, Norbert ^o   Lemaistre, Anne Isabelle ^p   Bérille, Jocelyne ^q   Denis, Bernard ^j   Conroy, Thierry ^f   Gérard, Jean Pierre ^g   more..

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b CENTRE VAL D AURELLE   (France)

^c CENTRE LÉON BÉRARD   (France)

^d FNCLCC   (France)

^e Laboratoire de Pathologie   (France)

^f CENTRE ALEXIS VAUTRIN   (France)

^g CENTRE ANTOINE LACASSAGNE   (France)

^h SERVICE DE DERMATOLOGIE   (France)

ⁱ CENTRE OSCAR LAMBRET   (France)

^j Pasteur Hospital   (France)

^k INSTITUT SAINTE CATHERINE   (France)

^l Laboratoire Medipath   (France)

^m HÔTEL DIEU   (France)

ⁿ INSTITUT BERGONIÉ   (France)

^o Laboratoire de Pathologie   (France)

^p Laboratoire de Pathologie   (France)

^q UNICANCER   (France)

more..

Author keywords

Circumferential resection margin; Preoperative radiochemotherapy; Rectal cancer

Indexed keywords

CAPECITABINE; OXALIPLATIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CHEMORADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER;

CHEMORADIOTHERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS;

EID: 84871432673     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.06.028     Document Type: Article

References (36)

1. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 17 2004 1731 1740
2. J.F. Bosset, L. Collette, and G. Calais Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 11 2006 1114 1123 (Pubitemid 44394918)
3. J.P. Gerard, T. Conroy, and F. Bonnetain Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203 J Clin Oncol 24 28 2006 4620 4625 (Pubitemid 46630960)
4. E. Kapiteijn, C.A. Marijnen, and I.D. Nagtegaal Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 9 2001 638 646
5. W. van Gijn, G.A. Gooiker, and M.W. Wouters Volume and outcome in colorectal cancer surgery Eur J Surg Oncol 36 Suppl. 1 2010 S55 S63
6. N. Smith, and G. Brown Preoperative staging of rectal cancer Acta Oncol 47 1 2008 20 31
7. N.J. Smith, Y. Barbachano, and A.R. Norman Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer Br J Surg 95 2 2008 229 236
8. M.J. Gosens, R.A. Klaassen, and I. Tan-Go Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma Clin Cancer Res 13 22 Pt. 1 2007 6617 6623 (Pubitemid 350206796)
9. I.D. Nagtegaal, and P. Quirke What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 26 2 2008 303 312
10. I.D. Nagtegaal, and J.H. van Krieken The role of pathologists in the quality control of diagnosis and treatment of rectal cancer-an overview Eur J Cancer 38 7 2002 964 972 (Pubitemid 34442324)
11. L.L. Gunderson, J.M. Jessup, and D.J. Sargent Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes J Clin Oncol 28 2 2010 256 263
12. P. Quirke, P. Durdey, and M.F. Dixon Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision Lancet 2 8514 1986 996 999 (Pubitemid 16005611)
13. J.P. Gerard, D. Azria, and S. Gourgou-Bourgade Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2 J Clin Oncol 28 10 2010 1638 1644
14. R.J. Heald, E.M. Husband, and R.D. Ryall The mesorectum in rectal cancer surgery-the clue to pelvic recurrence? Br J Surg 69 10 1982 613 616 (Pubitemid 12038080)
15. A. Rullier, and C. Laurent Recommendations for clinical practice. Therapeutic choices for rectal cancer. What quality criteria are important for surgical excision of rectal cancer? Gastroenterol Clin Biol 31 Spec. No. 1 2007 1S34-51, 1S91-5
16. C. Rodel, P. Martus, and T. Papadoupolos Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer J Clin Oncol 23 34 2005 8688 8696 (Pubitemid 46211512)
17. I.D. Nagtegaal, C.J. van de Velde, and C.A. Marijnen Low rectal cancer: a call for a change of approach in abdominoperineal resection J Clin Oncol 23 36 2005 9257 9264
18. M.T. Eriksen, A. Wibe, and A. Syse Inadvertent perforation during rectal cancer resection in Norway Br J Surg 91 2 2004 210 216 (Pubitemid 38233967)
19. A. Wibe, A. Syse, and E. Andersen Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection Dis Colon Rectum 47 1 2004 48 58 (Pubitemid 38040245)
20. D. Leonard, F. Penninckx, and S. Fieuws Factors predicting the quality of total mesorectal excision for rectal cancer Ann Surg 252 6 2010 982 988
21. N.P. West, C. Anderin, and K.J. Smith Multicentre experience with extralevator abdominoperineal excision for low rectal cancer Br J Surg 97 4 2010 588 599
22. J.F. Bosset, G. Calais, and L. Mineur Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results-EORTC 22921 J Clin Oncol 23 24 2005 5620 5627
23. H.H. Helgason, J.Y. Engwegen, and M. Zapatka Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry Oncol Rep 24 1 2010 57 64
24. S.K. Jeong, M.S. Kwon, and E.Y. Lee BiomarkerDigger: a versatile disease proteome database and analysis platform for the identification of plasma cancer biomarkers Proteomics 9 14 2009 3729 3740
25. J.H. Kang, Y.C. Kim, and H. Kim Tumor volume changes assessed by three-dimensional magnetic resonance volumetry in rectal cancer patients after preoperative chemoradiation: the impact of the volume reduction ratio on the prediction of pathologic complete response Int J Radiat Oncol Biol Phys 76 4 2010 1018 1025
26. R.K. Nibbe, and M.R. Chance Approaches to biomarkers in human colorectal cancer: looking back, to go forward Biomark Med 3 4 2009 385 396
27. A. Rullier, C. Laurent, and M. Capdepont Impact of tumor response on survival after radiochemotherapy in locally advanced rectal carcinoma Am J Surg Pathol 34 4 2010 562 568
28. A. Rullier, C. Laurent, and V. Vendrely Impact of colloid response on survival after preoperative radiotherapy in locally advanced rectal carcinoma Am J Surg Pathol 29 5 2005 602 606 (Pubitemid 40577869)
29. P.H. Chapuis, B.P. Lin, and C. Chan Risk factors for tumour present in a circumferential line of resection after excision of rectal cancer Br J Surg 93 7 2006 860 865 (Pubitemid 44035259)
30. H. Ueno, H. Mochizuki, and E. Shinto Histologic indices in biopsy specimens for estimating the probability of extended local spread in patients with rectal carcinoma Cancer 94 11 2002 2882 2891 (Pubitemid 34547687)
31. P.J. Guillou, P. Quirke, and H. Thorpe Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial Lancet 365 9472 2005 1718 1726 (Pubitemid 40719107)
32. I.D. Nagtegaal, C.A. Marijnen, and E.K. Kranenbarg Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit Am J Surg Pathol 26 3 2002 350 357 (Pubitemid 34184459)
33. P. Quirke, R. Steele, and J. Monson Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial Lancet 373 9666 2009 821 828
34. I.D. Nagtegaal, C.J. van de Velde, and E. van der Worp Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control J Clin Oncol 20 7 2002 1729 1734 (Pubitemid 34273260)
35. S. Maslekar, A. Sharma, and A. Macdonald Mesorectal grades predict recurrences after curative resection for rectal cancer Dis Colon Rectum 50 2 2007 168 175 (Pubitemid 46227212)
36. C. Aschele, L. Cionini, and S. Lonardi Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial J Clin Oncol 29 20 2011 2773 2780